Zhongnan Medical Journal Press

Home Results

A total of 7 result was found. Results that relate to Immune checkpoint inhibitor

Case report and literature analysis of hypothyroidism induced by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2023,32(2):227-232.
2076 times 851 times

Fei-Long TAN Hong-Ying XIA Zhong-Juan WANG Li DING Li-Na YOU Li ZHOU Jian JIN

Pembrolizumab Immune checkpoint inhibitors Hypothyroidism Adverse drug reaction
Details
A case of Immune-associated myocarditis in a tumor patient with diabetes mellitus

Published on Chinese Journal of Pharmacoepidemiology 2023,32(4):471-475.
1768 times 732 times

Min CHEN Ming-Wei ZHANG Wei AN Fei YAN

Tumor Diabetes Immune checkpoint inhibitors Myocarditis
Details
A case of immune myositis and peripheral neuropathy induced by immune checkpoint inhibitor

Published on Journal of Mathematical Medicine 2023,36(4):316-320.
2052 times 697 times

Tian-Zi XU Teng-Fei WANG Yi-Xin LIU Yong-Chang WEI

Immune checkpoint inhibitors Immune myositis Peripheral neuropathy Perihilar cholangiocarcinoma
Details
Progress of clinical research on immunotherapy and antibody-drug conjugates for the treatment of triple-negative breast cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):901-908.
2334 times 560 times

YANG Dan WANG Jinxiu MAO Dahua

Triple-negative breast cancer Immunotherapy Antibody-drug conjugates Clinical trials Immune checkpoint inhibitors Chemotherapy
Details
Research progress of immune checkpoint inhibitors in the treatment of glioblastoma

Published on New Medicine 2024,34(5):593-602.
2241 times 651 times

JIA Xiaorong ZHANG Gong

Glioblastoma Immunotherapy Immunocyte Immune checkpoint inhibitors
Details
Myocardial infarction induced by penpulimab and anlotinib: a case report

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):231-235.
965 times 132 times

WANG Chunhui JIANG Mengfei WU Wei ZHOU Yuhong

Immune checkpoint inhibitor Tyrosine kinase inhibitor Myocardial infarction Adverse drug reaction
Details
Clinical efficacy analysis of cross-line immunotherapy in driver gene-negative advanced non-small cell lung cancer patients

Published on New Medicine 2025,35(2):151-161.
982 times 309 times

WANG Yuankun LU Jiahao HU Jing XIE Conghua

Cross-line immunotherapy Non-small cell lung cancer Immune checkpoint inhibitors Prognosis Driver gene-negative
Details